1–3 of 3 results for Baruch D. Kuppermann
Avacincaptad Pegol, A Novel C5 Inhibitor, Reached Statistical Significance in a Pivotal Clinical Trial for Geographic Atrophy Secondary to Dry AMD
Baruch D. Kuppermann, MD, PhD
Annual Meeting Talks
2020
Gene Expression Modifications in Anti-VEGF Treated Retinal Müller Cells
2016
Safety and Activity of a Single, Intravitreal Injection of Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa (RP)
2018